Home › Compare › SPOFF vs ABBV
SPOFF yields 853.24% · ABBV yields 3.06%● Live data
📍 SPOFF pulled ahead of the other in Year 1
Combined, SPOFF + ABBV cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of SPOFF + ABBV for your $10,000?
EarthLabs Inc. operates as a technology services company in mineral exploration in Canada. The company operates in two segments, Exploration Technology Division and Financial Technology Division. The Exploration Technology Division segment offers LithoLens, a proprietary core imaging technology that automatically and consistently examines old core images to create fresh and accurate geological logs; MinusOne, a proprietary geophysical data inversion platform for creating 3-D models from geophysical data processed using deterministic and stochastic inversion methods; GeoFEZ, a processing software that extracts new insight from common exploration data, such as potential field data, topographic data, hyperspectral data, radiometric data, and electromagnetic data; and multi-parameter acquisition survey system, which allows the simultaneous capture of gradient magnetics, LiDAR, 4-band orthophoto imagery, and electromagnetic information in the very low frequency band and radiometric data. This segment also provides GeoticLog, a customizable core-logging platform; GeoticMine, a 3-D geological modelling and visualization solution; GeoticSection, a drill-hole visualizer; GeoticCAD, an industry tool with an integrated drawing motor; and GeoticField, a field-based survey data entry platform. The Financial Technology Division segment offers Resource Quantamental, an artificial intelligence decision engine for investments; CEO.CA, a social network for investors and traders in junior resource and venture stocks with online and mobile functionality; and DigiGeoAtlas platform, a software-based GIS interactive mapping interface alongside its DigiGeoMaps distribution business, as well as provides a range of cloud-based and interoperable web applications. This segment also provides smart targets, image analytics, geophysics, structural geology, geochemistry, and field geology services. The company was formerly known as GoldSpot Discoveries Corp. and changed its name to EarthLabs Inc. in September 2022. EarthLabs Inc. is headquartered in Toronto, Canada.
Full SPOFF Calculator →AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in adult patients; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and VENCLEXTA, a BCL-2 inhibitor used to treat adults with CLL or SLL; and MAVYRET to treat patients with chronic HCV genotype 1-6 infection. It also provides CREON, a pancreatic enzyme therapy for exocrine pancreatic insufficiency; Synthroid used in the treatment of hypothyroidism; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; Lupron for the palliative treatment of advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; and Botox therapeutic. In addition, the company offers ORILISSA, a nonpeptide small molecule gonadotropin-releasing hormone antagonist for women with moderate to severe endometriosis pain; Duopa and Duodopa, a levodopa-carbidopa intestinal gel to treat Parkinson's disease; Lumigan/Ganfort, a bimatoprost ophthalmic solution for the reduction of elevated intraocular pressure (IOP) in patients with open angle glaucoma (OAG) or ocular hypertension; Ubrelvy to treat migraine with or without aura in adults; Alphagan/ Combigan, an alpha-adrenergic receptor agonist for the reduction of IOP in patients with OAG; and Restasis, a calcineurin inhibitor immunosuppressant to increase tear production, as well as other eye care products. AbbVie Inc. has a research collaboration with Dragonfly Therapeutics, Inc. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.
Full ABBV Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.